Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
How do you counsel on the risks of developing anti-drug antibodies when using intrathecal enzyme replacement therapy for lysosomal storage disorders?
Related Questions
What factors do you consider when determining eligibility for hematopoietic stem cell therapies for metachromatic leukodystrophy?
Would you start antiseizure medications in tuberous sclerosis before seizure onset?
Are there specific tools that you request for an IEP of a child with dyslexia?
How do pediatric functional neurologic disorders differ from adult disorders in their presentation and diagnosis?
How do you discontinue ketogenic diets previously used as a treatment for epilepsy?
When do you consider cannabidiol for treatment of epilepsy?
Do you use alcohol to trigger seizures in patients you suspect to have JME to confirm diagnosis?
How do you decide when to pursue genetic testing for cerebral palsy?
When, if ever, do you use therapeutic hypothermia (targeted temperature management) in a non-neotal pediatric cardiac arrest patient?
How would you approach a toddler with alternating head tilt episodes lasting for weeks?
